| MDL | MFCD08458423 |
|---|---|
| Molecular Weight | 186.29 |
| Molecular Formula | C11H22O2 |
| SMILES | CCCCCC[C@H](C(O)=O)CCC |
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT00229177 | Ono Pharmaceutical Co. Ltd |
Stroke
|
September 2005 | Phase 2|Phase 3 |
| NCT00046761 | Ono Pharma USA Inc|Ono Pharmaceutical Co. Ltd |
Cerebrovascular Accident
|
November 2002 | Phase 2|Phase 3 |
Liquid
Room temperature in continental US; may vary elsewhere.
| Pure form | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
DMSO : 150 mg/mL ( 805.20 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 5.3680 mL | 26.8399 mL | 53.6797 mL |
| 5 mM | 1.0736 mL | 5.3680 mL | 10.7359 mL |
| 10 mM | 0.5368 mL | 2.6840 mL | 5.3680 mL |